Specific information about the role of mGlu2 and related treatment strategies for a wide range of neurodegenerative and neuropsychiatric diseases, including Alzheimer’s disease, schizophrenia and depression, can be found in a comprehensive review published by Li et al. [43]. Here, GRM2 is linked to early-onset autosomal dominant Alzheimer disease.